PartnershipsPAHEF Partnerships
PUBLIC and PRIVATE LEADERSHIPSince 1940, PAHEF has allied with local, national, and international corporations and foundations to enrich public health in the Americas. These public/private relationships are important and continue to be nurtured so that both strategic partners’ objectives are met. Often funding partners become engaged early on in a project to clearly understand its objectives or participate in the program design. Several partners may jointly fund a program to provide adequate resources to ensure its successful completion. We continue to develop ways to innovate and better serve the people of the Americas. Our partners help promote our work and increase the reach and visibility of PAHEF (and our colleagues at PAHO) through sponsorship, cause-marketing promotions, and activities that generate revenue and/or otherwise support and promote our mission. These important sustaining contributions not only provide financial resources for our public health programs, but give consumers more ways to support our cause. We are grateful to our corporate and foundation partners for their support. PAHEF invites you to explore ways to become a strategic partner:
A STRONG AND POWERFUL PARTNERSupport PAHEF and our activities and you will help provide our public health technical experts, whether they are from PAHO (Pan American Health Organization) or non-governmental organizations in Latin America, the resources needed for successful project implementation. IMPACTFUL RESULTSPAHEF thanks Sanofi for their commitment to funding a recent study on dengue. According to WHO, “Dengue is transmitted by the bite of an Aedes mosquito infected with any one of the four dengue viruses. It occurs in tropical and sub-tropical areas of the world. Symptoms appear 3—14 days after the infective bite. Dengue fever is a febrile illness that affects infants, young children and adults. Symptoms range from a mild fever, to incapacitating high fever, with severe headache, pain behind the eyes, muscle and joint pain, and rash. Dengue haemorrhagic fever (fever, abdominal pain, vomiting, bleeding) is a potentially lethal complication, affecting mainly children.” Thanks to a generous gift, PAHEF was able to commission a study with Johns Hopkins University on dengue as part of a regional initiative to develop sound methodologies and approaches for estimating the socio-economic costs of dengue in the Americas. This document is meant to provide guidance for developing studies on estimating socioeconomic costs of dengue. It is hoped that these guidelines will be helpful to all countries in the Americas. When undertaking costing studies, guideline users are strongly advised to focus on a particular setting. Similarly, local dengue surveillance data in the country should be available. Download and read the complete guidelines: Costing Dengue Cases And Outbreaks: A Guide To Current Practices And Procedures, via the related Success Story. FOR MORE INFORMATIONIf you are looking for opportunities to do business with PAHEF, please review our open call for tenders. If you would like to explore other opportunities, Elly Brtva, Vice President, Chief Philanthropy Officer is available to discuss these opportunities. Reach her at This email address is being protected from spambots. You need JavaScript enabled to view it. or at 202-974-3845. Please note: until a fully-executed agreement is received, use of the PAHEF name and logo is prohibited.
|
Nomination Deadline
06.14.2013 17:00 hs
23
|